A Lancet Regional Health study warns that HbA1c, India's most used diabetes test, may misdiagnose or delay detection due to ...

Doctors warn that heavy reliance on HbA1c for diabetes diagnosis in India may lead to under- or over-diagnosis due to high anaemia and kidney disease burden, urging multiparametric testing ...

Most people assume diabetes is easy to diagnose. You take a blood test, get a number, and that’s it. But in real life, it’s ...

A new evidence-based viewpoint published online in Lancet Regional Health: Southeast Asia highlights that the widely used ...

The consensus is emerging that public health surveys based solely on HbA1c may misrepresent India's diabetes burden.

Researchers are cautioning against relying solely on glycated haemoglobin, ‘HbA1c’, for diagnosing and monitoring diabetes in ...

HbA1c and continuous glucose monitoring metrics, such as mean glucose and time in range, may not be correlated for some adults with type 2 diabetes, according to study data. The two measures should be ...

A Lancet review warns that the HbA1c test, widely used in India, may give misleading results for diabetes diagnosis.

Adults with type 2 diabetes who used an automated insulin delivery system had greater improvements in HbA1c than controls ...

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and ...

Experts warn that relying solely on HbA1c for diagnosing type-2 diabetes in India may lead to misleading results.

Reinforces Trinity Biotech’s growing position as a key player in diabetes care innovation– Senior commercial executives of Trinity Biotech are ...